Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00821132 · ClinicalTrials.gov registry record
Genetics of Familial and Sporadic ALS
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 13,521
- Enrollment target
NCT00821132 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 13,521 participants.
The verdict
NCT00821132 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 13,521 participants
- Enrollment target
Study Summary
We are collecting blood samples, clinical and family information from ALS (amyotrophic lateral sclerosis) patients and their families to identify causes of ALS and ALS/dementia.
Interventions
- OTHER Genetic study of ALS families
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,521 participants |
| Start Date | 1991-01 |
| Est. Completion | 2023-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00821132
The ClinicalTrials.gov registry entry for NCT00821132 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13,521 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genetic study of ALS families is the first listed.
NCT00821132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00821132 about?
NCT00821132 is a clinical study titled "Genetics of Familial and Sporadic ALS". We are collecting blood samples, clinical and family information from ALS (amyotrophic lateral sclerosis) patients and their families to identify causes of ALS and ALS/dementia.
What is the current status of trial NCT00821132?
This trial is currently completed. The enrollment target is 13,521 participants. The study started on 1991-01. Estimated completion is 2023-01.
What interventions are being tested in trial NCT00821132?
The interventions under investigation include: Genetic study of ALS families (OTHER).
Who is sponsoring clinical trial NCT00821132?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.